D. Peretti, C. Chin, F. Tuppin, and P. , Personnes hospitalisées pour infarctus du myocarde en France: tendances 2002-2008, BEH, Bull épidémiol hebd, issue.41, pp.459-465, 2012.

N. Danchin, E. Puymirat, N. Aissaoui, S. Adavane, and E. Durand, ??pid??miologie des syndromes coronaires aigus en France et en Europe, Annales de Cardiologie et d'Ang??iologie, vol.59, pp.37-41, 2010.
DOI : 10.1016/S0003-3928(10)70008-1

M. Gouffrant, STEMI : la mortalité diminue grâce à une meilleure prise en charge globale. European Society of Cardiology (ESC) Aout 2012. Munich : Consensus de cardiologie pour le praticien, pp.29-30, 2012.

N. Danchin and . Fast-mi-programme, Decrease in early mortality in STEMI is related to changing patient profile and behavior, as well as improved organization of care: Data from 4 French nationwide surveys over 15 years

. Steg-pg and S. James, ESC Guidelines for the management of acute myocardial infarction in patients presenting with St-segment elevation :the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart j, vol.33, pp.2569-619, 2012.

Z. Reiner, A. Catapano, D. Backer, G. Graham, I. Taskinen et al., EAS Guidelines for the management of dyslipidaemias : The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, vol.32, issue.14, pp.1796-818, 2011.

E. Recommandation, pour la prise en charge de l'hypertension artérielle, Journal of hypertension, vol.25, pp.1105-87, 2007.

J. Blacher, J. Halimi, O. Hanon, J. Mourad, A. Pathak et al., SFHTA, société française hypertension artérielle. Recommandation: prise en charge de l'hypertension artérielle de l'adulte

F. Delahaye, M. Bory, and A. Cohen, Recommandations de la Société Française de cardiologie concernant la prise en charge de l'infarctus du myocarde après la phase aiguë, Arch Cardiovasc Dis, vol.94, issue.7, pp.697-738, 2001.

S. Yusuf, J. Wittes, and L. Friedman, Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction, JAMA: The Journal of the American Medical Association, vol.260, issue.14, pp.2088-93, 1988.
DOI : 10.1001/jama.260.14.2088

M. Seronde, Cours: inhibiteurs de l'enzyme de conversion(IEC)

M. Pffer, E. Braunwald, L. Moyé, L. Basta, E. Brouwn et al., Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction, New England Journal of Medicine, vol.327, issue.10, pp.669-77, 1992.
DOI : 10.1056/NEJM199209033271001

K. M. Fox, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacity of perindopril in reduction of cardiovascular events among patients with stable coronary artery desease. The EUROPA Study, Lancet, vol.362, pp.782-788, 2003.

M. Bertrand, J. Bassand, and R. Ferrari, La prévention des évènements cardiaques avec le périndopril dans la coronaropathie -L'étude EUROPA, 2003.

O. Kusnik-joinville, A. Weill, P. Ricordeau, and H. Allemand, Diabète traité en France en 2007 : un taux de prévalence proche de 4% et des disparités géographiques croissantes, Bull Epidémiol Hebd, issue.43, pp.409-420, 2008.

P. Ricci, P. Blotiere, A. Weill, D. Simon, and T. P. , Diabète traité : quelles évolutions entre, Bull Epidémiol Hebd, pp.42-43425, 2000.

C. Bogdan and . Has, Syndrome coronaires aigus et diabète : prise en charge spécifique en cardiologie au décours d'un syndrome coronarien aigu. Mars Available From : www.has sante, 2007.

K. Malmberg, A. Norhammar, H. Wedel, and L. Ryden, Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study, Circulation, vol.99, issue.20, pp.2626-2658, 1999.
DOI : 10.1161/01.CIR.99.20.2626

J. Lipton, R. Barendse, R. Van-dombourg, and A. Schinkel, Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unit. Eur Heart J Acute Cardiovasc Care, pp.306-313, 2013.

K. Malmberg, L. Ryden, and H. Wedel, Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity, European Heart Journal, vol.26, issue.7, pp.650-61, 2005.
DOI : 10.1093/eurheartj/ehi199

B. Verges, les effets pléiotropes des statines ont-ils un intérêt clinique ? Archive des maladies du coeur et des vaisseaux, pp.1231-1235, 2004.

D. Karila-cohen, Aspirine et pr??vention du risque cardiovasculaire, La Revue de M??decine Interne, vol.21, issue.1, pp.35-40, 2000.
DOI : 10.1016/S0248-8663(00)88723-8

K. Fox, S. Mehta, and R. Peters, Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial/ Circulation, pp.1202-1208, 2004.

S. Wiviott, E. Braunwald, and C. Mccabe, TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 2007.

C. Cannon, R. Harrington, and S. James, Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study, The Lancet, vol.375, issue.9711, pp.283-293, 2010.
DOI : 10.1016/S0140-6736(09)62191-7

B. Pavy, M. Iliou, and B. , French society of cardiologie guidelines for cardiac rehabilitation in adults, Arch Cardiovasc Dis, vol.05, pp.309-337, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00905445

B. Pavy, Therapeutic education in coronary heart disease: Position paper from the Working Group of Exercise Rehabilitation and Sport (GERS) and the Therapeutic Education Commission of the French Society of Cardiology, Archives of Cardiovascular Diseases, vol.106, issue.12, 2013.
DOI : 10.1016/j.acvd.2013.10.002

F. Carre, Activité physique dans la prévention de la maladie coronarienne

M. Ghannem, La r??adaptation cardiaque en post-infarctus du myocarde, Annales de Cardiologie et d'Ang??iologie, vol.59, issue.6, pp.367-379, 2010.
DOI : 10.1016/j.ancard.2010.10.001

B. Grenier, Le d??veloppement de l'??ducation th??rapeutique en France : politiques publiques et offres de soins actuelles, Sant?? Publique, vol.19, issue.4, pp.283-292, 2007.
DOI : 10.3917/spub.074.0283

J. Foucaud, M. Balcou-debussche, and . Dir, Former à l'éducation du patient : quelles compétences? Réflexions autour du séminaire de Lille, 11-13 octobre, 2006.

J. Foucaud, J. Bury, M. Balcou-debussche, C. Eymard, and . Dir, Éducation thérapeutique du patient. Modèles, pratiques et évaluation. Saint-Denis : INPES, coll. Santé en action, 2010.

J. Ferrieres, I. Durack-bown, and P. Giral, ??ducation th??rapeutique et??patient ????haut risque??: une??nouvelle approche en??cardiologie, Annales de Cardiologie et d'Ang??iologie, vol.55, issue.1, pp.27-31, 2006.
DOI : 10.1016/j.ancard.2005.10.002

D. Wood, EUROACTION: a nurse lead multidisciplinary preventive cardiology programme for coronary patients, high risk individuals and their families. Hot Line I

. Frans-van-de-werf, management of acute myocardial infarction in patients presenting with ST-segment elevation. The task Force on the Management of acute myocardial infarction of the European Society of Cardiology, Eur Heart j, vol.24, pp.28-66, 2003.

T. Denolle, A. Sharareh, and M. Dib, Efficacité d'un réseau pour la prévention secondaire des patients coronariens, Archives des maladies du coeur et des vaisseaux, vol.100, issue.8, pp.625-634, 2007.

A. Golay, G. Lagger, and A. Giordan, Comment motiver le patient à changer ? Paris : Maloine, 2010.

J. Cambou, T. Simon, G. Mulak, V. Bataille, and N. Danchin, The French registry of Acute ST elevation or non -ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics, Arch cardiovasc Dis, vol.100, issue.67, pp.524-558, 2007.

A. Tombette, Evaluation de la prévention secondaire des patients pris en charge au centre hospitalier de saint-Brieuc pour un infarctus du myocarde avec sus-décalage du ST et inclus dans l'observatoire ORBI, Thèse méd. Rennes, p.29, 2012.

I. Group, Clinical reality of coronary prevention guidelines: a comparison of EuroAspire I and II in nine countries, Lancet, vol.357, pp.995-1001, 2001.

. Laffitte-m, V. Pradeau, and L. Leroux, Efficacy over time of a short overall atherosclerosis management programme on the reduction of cardiovascular risk in patients after an acute coronary syndrome, Archives of Cardiovascular Diseases, vol.102, issue.1, pp.51-58, 2009.
DOI : 10.1016/j.acvd.2008.09.014

M. Labrunée, Therapeutic education in cardiovascular diseases: State of the art and perspectives, Annals of Physical and Rehabilitation Medicine, vol.55, issue.5, pp.322-341, 2012.
DOI : 10.1016/j.rehab.2012.04.003

J. Seidell, T. Visscher, and R. Hoogeveen, Overweight and obesity in the mortality rate data: current evidence and research issues, Medicine & Science in Sports & Exercise, vol.31, issue.Supplement 1, pp.597-601, 1999.
DOI : 10.1097/00005768-199911001-00018

R. Auer, D. Morin, and R. Darioli, Approche éducationnelle des patients à risque cardiovasculaire, Rev Med Suisse, vol.4, pp.657-60, 2008.